GLG Inc’s United Therapeutics UTHR Stock Holding History

GLG Inc’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-50,954	Closed	-$4.02M	–	731
2013 Q3	$4.02M	Buy	+50,954	New	+$3.72M	0.08%	284

Other funds holding UTHR

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

HCM

Herndon Capital Management Atlanta, Georgia $659M AUM 22.02% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GLG Inc's UTHR Position: Q4 2013 in Review

GLG Inc sold out of United Therapeutics (UTHR) in Q4 2013, closing a stake of 50,954 shares — an estimated $4.02M sold.

GLG Inc first reported a position in UTHR in Q3 2013 and held it in 1 quarter. The position peaked at $4.02M in Q3 2013. 321 funds tracked by Wall St. Rank hold UTHR as of Q4 2013.

GLG Inc reported no remaining United Therapeutics position as of Q4 2013 after selling out during the quarter.
GLG Inc sold 50,954 United Therapeutics shares in Q4 2013, an estimated $4.02M.
GLG Inc first reported a position in United Therapeutics in Q3 2013 and held it in 1 quarter.
GLG Inc's United Therapeutics position peaked at $4.02M in Q3 2013.
321 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2013.

Based on GLG Inc's 13F filing for Q4 2013, filed 14 Feb 2014.